Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Cash Flows From Operating Activities:    
Net loss $ (10,116) $ (15,380)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 350 340
Subsidiary stock issuances to vendor 178 72
Depreciation 201 240
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (326) (788)
Right of use asset 141 118
Accounts payable (1,429) 1,282
Accrued expenses (851) 857
Accrued employee benefits (67) (397)
Lease liability (249) (217)
Net Cash Used In Operating Activities (12,168) (13,873)
Cash Flows From Investing Activities:    
Purchases of property and equipment (9) 0
Net Cash Used In Investing Activities (9) 0
Cash Flows From Financing Activities:    
Proceeds from "at-the-market" stock issuance 3,359 0
Net Cash Provided By Financing Activities 3,359 0
Net decrease in cash (8,818) (13,873)
Cash and cash equivalents at beginning of year 15,045 28,918
Cash and cash equivalents at end of year 6,227 15,045
NONCASH FINANCING ACTIVITIES:    
Conversion of Series B Preferred Stock 2,284 999
Effect of Warrant exercise price adjustment 880 0
In-kind dividends paid in preferred stock 254 248
Right of use assets from operating lease 0 537
Series B Preferred Stock [Member]    
NONCASH FINANCING ACTIVITIES:    
Deemed dividends for accretion of Series B Preferred Stock discount $ 1,380 $ 525